Laman Utama8QQ • FRA
add
AbCellera Biologics Inc
Tutup sebelumnya
€1.78
Julat hari
€1.78 - €1.78
Julat tahun
€1.70 - €3.79
Permodalan pasaran
588.01J USD
Bilangan Purata
448.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Hasil | 4.24J | -57.45% |
Perbelanjaan pengendalian | 24.40J | -4.55% |
Pendapatan bersih | -45.62J | -12.34% |
Margin untung bersih | -1.08K | -164.04% |
Pendapatan bagi setiap syer | -0.15 | -7.14% |
EBITDA | -57.33J | -14.54% |
Kadar cukai berkesan | 13.90% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 605.27J | -13.29% |
Jumlah aset | 1.34B | -8.13% |
Jumlah liabiliti | 321.23J | -3.59% |
Jumlah ekuiti | 1.02B | — |
Syer tertunggak | 298.48J | — |
Harga kepada buku | 0.52 | — |
Pulangan pada aset | -11.58% | — |
Pulangan pada modal | -14.16% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -45.62J | -12.34% |
Tunai daripada operasi | -11.55J | 72.30% |
Tunai daripada pelaburan | 7.94J | -73.47% |
Tunai daripada pembiayaan | 5.97J | 110.88% |
Perubahan bersih dalam tunai | 2.94J | 130.17% |
Aliran tunai bebas | -63.60J | -21.59% |
Perihal
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Diasaskan
2012
Ibu pejabat
Tapak web
Pekerja
596